Enes Kumcu

Dr. Enes Kumcu

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 July 2025 in American Journal of Reproductive Immunology
Verified
Journal Article
Closed access
MDMurat Levent Dereli
Murat Levent Dereli
SSSadun Sucu
Sadun Sucu
AKAhmet Kurt
Ahmet Kurt
EKEnes Kumcu
Enes Kumcu
EMEmre Mat
Emre Mat
AÇali turhan çağlar
ali turhan çağlar

29 January 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
PKPinar Karacin
Pinar Karacin
RÖRuna Özelçi
Runa Özelçi
EKEnes Kumcu
Enes Kumcu
DKDilek Kaya Kaplanoğlu
Dilek Kaya Kaplanoğlu
SDSerdar Dilbaz
Serdar Dilbaz
YEYaprak Engin-Üstün
Yaprak Engin-Üstün
Objective: In this study, we aimed to develop and internally validate a clinically applicable nomogram for predicting live birth following in vitro fertilization (IVF) using routinely available clinical and embryological parameters. Methods: This retrospective study was conducted at a single tertiary IVF center. Women undergoing IVF/ICSI were included if their baseline demographic and clinical data were available, they had undergone at least one fresh or frozen–thawed embryo transfer, and they had a known live birth outcome. Women with cycles without embryo transfer and those missing key outcome data were excluded from the analysis. As a result, a total of 2119 IVF/ICSI treatment cycles resulting in embryo transfer were included in the analysis. To identify independent predictors of live birth, multivariable logistic regression analysis was performed. Results: Among the 2119 treatment cycles analyzed, 541 resulted in live birth (25.5%). Multivariable logistic regression with backward stepwise selection identified female age (OR: 0.959, p < 0.001), high embryo quality (OR: 2.752, p < 0.001), day of embryo transfer (day 5 vs. day 3, OR: 1.427, p = 0.001), and endometrial thickness on the day of transfer as independent predictors of live birth (OR: 1.086, p < 0.001). These variables were incorporated into a nomogram (the Zübeyde Hanim IVF Nomogram) to estimate individualized live birth probability. The model demonstrated acceptable discrimination, with a bootstrap-corrected area under the receiver operating characteristic curve (AUC) of 0.64 (95%CI: 0.61–0.66), and it showed satisfactory calibration across deciles of predicted risk. Conclusions: The Zubeyde Hanim IVF Nomogram provides an individualized and clinically practical tool for predicting live birth following IVF treatment. Based on routinely available parameters, this model may assist clinicians in patient counseling and treatment planning.

17 April 2025 in Medicina
Verified
Journal Article
Open access
PDF file
PKPinar Karacin
Pinar Karacin
RÖRuna Özelçi
Runa Özelçi
EKEnes Kumcu
Enes Kumcu
DKDilek Kaya Kaplanoğlu
Dilek Kaya Kaplanoğlu
SDSerdar Dilbaz
Serdar Dilbaz
YEYaprak Engin-Üstün
Yaprak Engin-Üstün
Background and Objectives: The aim of this study is to evaluate the relationship between serum estradiol (E2) levels measured on the day of antagonist administration and live birth rates (LBRs) in women undergoing IVF-ET with an antagonist protocol. Materials and Methods: Data from women who underwent IVF-ET with an antagonist protocol between 2011 and 2023 were retrospectively analyzed. Patients were divided into five groups on the basis of serum E2 levels measured on the day of antagonist administration (Group I: E2 < 400 pg/mL, Group II: 400 ≤ E2 < 650 pg/mL, Group III: 650 ≤ E2 < 800 pg/mL, Group IV:800 ≤ E2 < 1000 pg/mL, and Group V: E2 ≥ 1000 pg/mL). The independent effect of serum E2 levels on live birth was analyzed via an adjusted regression model. Results: A total of 1613 patients were included in the study. The overall LBR was 32.1%. The LBRs for Groups I, II, III, IV, and V were 28.9%, 37.8%, 26.4%, 32.2%, and 34.1%, respectively (p = 0.017). In the adjusted regression model, serum E2 levels measured on the day of antagonist administration < 400 pg/mL (OR: 0.752, 95% CI: 0.580–0.999, p = 0.048) and 650 ≤ E2 < 800 pg/mL (OR: 0.595, 95% CI: 0.388–0.911, p = 0.011) were identified as factors that reduce the likelihood of a live birth, adjusting for age, infertility duration, body mass index (BMI), cycle number, quality of embryo, and number of embryos transferred. Conclusions: The serum E2 level associated with the highest LBR in women undergoing IVF-ET with an antagonist protocol was found to be in the range of 400–650. Serum E2 levels < 400 pg/mL or in the range of 650–800 pg/mL were statistically significantly associated with a reduced LBR.

9 June 2026
Verified
Book Chapter
Closed access
EKEnes Kumcu
Enes Kumcu
SDSerdar Dilbaz
Serdar Dilbaz